Form 4: Beta Bionics CEO Sean Saint Reports Stock Option Grant

Sean Saint, CEO of Beta Bionics, reports the acquisition of stock options exercisable for 467,944 shares of Class B Common Stock (later converted to Common Stock) on January 29, 2025.

Summary

• This is a Form 4 filing, indicating a change in beneficial ownership of securities.
• Sean Saint, the President & CEO of Beta Bionics, Inc. [BBNX], was granted employee stock options on January 29, 2025.
• The options are for 467,944 shares of Class B Common Stock, with an exercise price of $17.
• The options vest monthly over a 48-month period starting January 29, 2025.
• Prior to the IPO, each share of Class B Common Stock subject to the option was converted into Common Stock.
• The options expire on January 28, 2035.
• Following the transaction, Saint directly owns options for 467,944 shares.

Sentiment

Score: 7

Explanation: The document itself is neutral, simply reporting a stock option grant. It's a standard practice, and the vesting schedule suggests a long-term commitment from the CEO, which is generally viewed positively.

Positives

• The grant of stock options to the CEO aligns his interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the CEO.

Industry Context

Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the biotech industry.
• The vesting schedule of 48 months is typical for such grants.
• The size of the grant should be compared to grants made to executives at comparable companies to assess its relative value.

Stakeholder Impact

• Shareholders: The stock option grant aligns the CEO's interests with those of the shareholders, incentivizing him to increase shareholder value.
• Employees: The grant could have a positive impact on employee morale, as it demonstrates the company's commitment to its leadership.

Key Dates